Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir long-term extension study in chronic hepatitis B
ACTRN12606000283572Phase 4Recruiting
- Sponsor
- Concord Hospital
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by Concord Hospital. Primary endpoints: Proportion of treatment failures: virologic failure, Proportion of treatment failures: development of genotypic resistance and 1 more. Started Jul 2006; status: recruiting.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ACTRN12606000283572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000283572.